Ubp Investment Advisors Sa Exact Sciences Corp Transaction History

Ubp Investment Advisors Sa

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$93.66 - $139.27 $280,980 - $417,810	-3,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $99,610 - $142,120	1,000 Added 50.0%	3,000 $397,000
Q3 2020 Oct 22, 2020	SELL	$72.92 - $102.01 $72,920 - $102,010	-1,000 Reduced 33.33%	2,000 $306,000
Q2 2020 Aug 05, 2020	BUY	$55.75 - $92.75 $167,250 - $278,250	3,000 New	3,000 $261,000
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $132,650 - $365,540	-3,500 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$77.66 - $99.74 $62,128 - $79,792	800 Added 29.63%	3,500 $324,000
Q3 2019 Nov 13, 2019	BUY	$90.37 - $122.49 $9,037 - $12,249	100 Added 3.85%	2,700 $244,000
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $62,657 - $82,628	-700 Reduced 21.21%	2,600 $307,000
Q1 2019 Apr 29, 2019	BUY	$61.98 - $96.5 $204,534 - $318,450	3,300 New	3,300 $286,000
Q4 2018 Feb 04, 2019	SELL	$56.04 - $82.66 $162,516 - $239,714	-2,900 Closed	0 $0
Q3 2018 Oct 10, 2018	BUY	$48.29 - $80.6 $140,041 - $233,739	2,900 New	2,900 $229,000

609

166M

1.93M

1.23M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.8B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Ubp Investment Advisors Sa, based on Form 13F filings with the SEC.

Stay updated on Ubp Investment Advisors Sa with notifications on news.